Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Tina Primeau
Affiliation
ORCID
Career Start Year
2003
Papers
19
H Index
12
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
34996889
Author Correction: Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment.
Nat Commun
2022
36395883
Diptoindonesin G is a middle domain HSP90 modulator for cancer treatment.
Journal of Biological Chemistry
2022
34429404
Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatment.
Nat Commun
2021
33591953
Chromosome 8 gain is associated with high-grade transformation in MPNST.
JCI Insight
2021
34011995
Mismatch repair deficiency predicts response to HER2 blockade in HER2-negative breast cancer.
Nature Communications
2021
33355448
Hyaluronan-Conjugated Carbon Quantum Dots for Bioimaging Use.
ACS applied materials & interfaces
2021
34902246
Macrocyclic Inhibitors of HGF-Activating Serine Proteases Overcome Resistance to Receptor Tyrosine Kinase Inhibitors and Block Lung Cancer Progression.
Journal of Medicinal Chemistry
2021
33371187
Proteomic Resistance Biomarkers for PI3K Inhibitor in Triple Negative Breast Cancer Patient-Derived Xenograft Models.
Cancers (Basel)
2020
31196969
Regulated Phosphosignaling Associated with Breast Cancer Subtypes and Druggability.
Mol Cell Proteomics
2019
30518672
Cooperative Effect of Oncogenic <i>MET</i> and <i>PIK3CA</i> in an HGF-Dominant Environment in Breast Cancer.
Mol Cancer Ther
2019
31074257
Assessment of Copper Nanoclusters for Accurate in Vivo Tumor Imaging and Potential for Translation.
ACS applied materials & interfaces
2019
31369274
Folate Receptor α-Targeted Zr-M9346A Immuno-PET for Image-Guided Intervention with Mirvetuximab Soravtansine in Triple-Negative Breast Cancer.
Molecular Pharmaceutics
2019
29472518
Mass Spectrometry-Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers.
Cancer Res
2018
28619968
Breast Cancer Neoantigens Can Induce CD8<sup>+</sup> T-Cell Responses and Antitumor Immunity.
Cancer Immunol Res
2017
25991817
Efficacy of SERD/SERM Hybrid-CDK4/6 Inhibitor Combinations in Models of Endocrine Therapy-Resistant Breast Cancer.
Clin Cancer Res
2015
19892989
A single peptide-MHC complex positively selects a diverse and specific CD8 T cell repertoire.
Science
2009
16698321
Mucopolysaccharidosis I cats mount a cytotoxic T lymphocyte response after neonatal gene therapy that can be blocked with CTLA4-Ig.
Molecular Therapy
2006
16106063
Applications of major histocompatibility complex class I molecules expressed as single chains.
Immunologic Research
2005
12732632
Enhanced immune presentation of a single-chain major histocompatibility complex class I molecule engineered to optimize linkage of a C-terminally extended peptide.
Journal of Biological Chemistry
2003
1 - 19 of 19
Column Actions
Search
Recommended Authors
Collaborators
Shunqiang Li
Co-authored papers
15
Matthew J Ellis
Co-authored papers
8
Sherri R Davies
Co-authored papers
5
Jeremy Hoog
Co-authored papers
5
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers
5
Ted H Hansen
Co-authored papers
4
Cynthia X Ma
Co-authored papers
4
Feng Chen
Washington University in St Louis
Co-authored papers
3
Song Cao
Washington University in St Louis
Co-authored papers
3
Robert J Mashl
Washington University in St. Louis
Co-authored papers
3
Matthew H Bailey
Department of Biology at Brigham Young University
Co-authored papers
2
Michael A Davies
The University of Texas MD Anderson Cancer Center
Co-authored papers
2
Matthew A Wyczalkowski
Washington University in St Louis
Co-authored papers
2
Reyka G Jayasinghe
Washington University in St Louis
Co-authored papers
2
Ramaswamy Govindan
Siteman Cancer Center, Washington University School of Medicine
Co-authored papers
2
Kuan-Lin Huang
Icahn School of Medicine at Mount Sinai
Co-authored papers
2
James H Doroshow
National Cancer Institute, National Institutes of Health
Co-authored papers
2
Funda Meric-Bernstam
University of Texas MD Anderson Cancer Center
Co-authored papers
2
Michael T Lewis
Baylor College of Medicine
Co-authored papers
2
Kelly V Ruggles
Co-authored papers
2
David Feny??
Institute for Systems Genetics, NYU Grossman School of Medicine
Co-authored papers
2
Chia-Kuei Mo
Co-authored papers
2
Michael C Wendl
Washington University in St Louis
Co-authored papers
2
Meenhard Herlyn
Ellen and Ronald Caplan Cancer Center, The Wistar Institute
Co-authored papers
2
Yvonne A Evrard
Frederick National Laboratory for Cancer Research, Inc.
Co-authored papers
2
John F DiPersio
Washington University School of Medicine
Co-authored papers
2
Steven A Carr
Broad Institute of MIT and Harvard
Co-authored papers
2
Zhanfang Guo
Co-authored papers
2
Nadezhda V Terekhanova
Co-authored papers
2
Yize Li
Co-authored papers
2
1 - 30